| Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review L Degenhardt, A Peacock, S Colledge, J Leung, J Grebely, P Vickerman, ... The Lancet Global Health 5 (12), e1192-e1207, 2017 | 1356 | 2017 |
| Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill, HM Crane, ... The lancet HIV 4 (8), e349-e356, 2017 | 1099 | 2017 |
| Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 H Wang, TM Wolock, A Carter, G Nguyen, HH Kyu, E Gakidou, SI Hay, ... The lancet HIV 3 (8), e361-e387, 2016 | 780 | 2016 |
| Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs J Grebely, S Larney, A Peacock, S Colledge, J Leung, M Hickman, ... Addiction 114 (1), 150-166, 2019 | 237 | 2019 |
| Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis J Stone, H Fraser, AG Lim, JG Walker, Z Ward, L MacGregor, A Trickey, ... The Lancet Infectious Diseases 18 (12), 1397-1409, 2018 | 208 | 2018 |
| The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study A Trickey, H Fraser, AG Lim, A Peacock, S Colledge, JG Walker, J Leung, ... The lancet Gastroenterology & hepatology 4 (6), 435-444, 2019 | 188 | 2019 |
| Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis E Oru, A Trickey, R Shirali, S Kanters, P Easterbrook The Lancet Global Health 9 (4), e431-e445, 2021 | 139 | 2021 |
| Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy A Trickey, MT May, J Vehreschild, N Obel, MJ Gill, H Crane, C Boesecke, ... PloS one 11 (8), e0160460, 2016 | 132 | 2016 |
| Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis C Arum, H Fraser, AA Artenie, S Bivegete, A Trickey, M Alary, ... The Lancet public health 6 (5), e309-e323, 2021 | 127 | 2021 |
| SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: a prospective cohort study in keyworkers D Wyllie, R Mulchandani, HE Jones, S Taylor-Phillips, T Brooks, ... MedRxiv, 2020.11. 02.20222778, 2020 | 110 | 2020 |
| Prevalence and burden of HBV co‐infection among people living with HIV: a global systematic review and meta‐analysis L Platt, CE French, CR McGowan, K Sabin, E Gower, A Trickey, ... Journal of viral hepatitis 27 (3), 294-315, 2020 | 104 | 2020 |
| CD4: CD8 ratio and CD8 count as prognostic markers for mortality in human immunodeficiency virus–infected patients on antiretroviral therapy: the Antiretroviral Therapy Cohort … A Trickey, MT May, P Schommers, J Tate, SM Ingle, JL Guest, MJ Gill, ... Clinical Infectious Diseases 65 (6), 959-966, 2017 | 99 | 2017 |
| The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis S Colledge, A Peacock, J Leung, S Larney, J Grebely, M Hickman, ... International Journal of Drug Policy 73, 172-184, 2019 | 96 | 2019 |
| Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data A Kaura, JAC Sterne, A Trickey, S Abbott, A Mulla, B Glampson, ... The Lancet 396 (10251), 623-634, 2020 | 92 | 2020 |
| Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination AG Lim, H Qureshi, H Mahmood, S Hamid, CF Davies, A Trickey, N Glass, ... International journal of epidemiology 47 (2), 550-560, 2018 | 90 | 2018 |
| Mortality according to CD4 count at start of combination antiretroviral therapy among HIV-infected patients followed for up to 15 years after start of treatment: collaborative … MT May, JJ Vehreschild, A Trickey, N Obel, P Reiss, F Bonnet, ... Clinical Infectious Diseases 62 (12), 1571-1577, 2016 | 84 | 2016 |
| High COVID-19 transmission potential associated with re-opening universities can be mitigated with layered interventions E Brooks-Pollock, H Christensen, A Trickey, G Hemani, E Nixon, ... Nature communications 12 (1), 5017, 2021 | 69 | 2021 |
| Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies A Trickey, CA Sabin, G Burkholder, H Crane, AA Monforte, M Egger, ... The Lancet HIV 10 (5), e295-e307, 2023 | 62 | 2023 |
| The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study RL O’Connell, T Rattay, RV Dave, A Trickey, J Skillman, NLP Barnes, ... British Journal of Cancer 120 (9), 883-895, 2019 | 60 | 2019 |
| The relationship between left ventricular wall thickness, myocardial shortening, and ejection fraction in hypertensive heart disease: insights from cardiac magnetic resonance … JCL Rodrigues, S Rohan, AG Dastidar, A Trickey, G Szantho, ... The journal of clinical hypertension 18 (11), 1119-1127, 2016 | 47 | 2016 |
